A research study published in the July issue of the Journal of the American College of Cardiology reports that genetic mutations in a neuronal sodium channel gene are associated with inherited sudden cardiac death syndromes, including the Brugada syndrome. The study, performed at the Cardiac Research Institute at Masonic Medical Research Laboratory (MMRL) in Utica, N.Y., included physicians and scientists from throughout the world who referred patients with life-threatening cardiac arrhythmias to the MMRL for genetic screening.

Akers Biosciences Inc. has signed a feasibility study deal with Konica Minolta Inc. to develop a rapid test for the early detection of myocardial infarction. Heart attacks are the leading cause of death in United States, with approximately 1.1 million Americans suffering heart attacks each year.

The electrophysiology service of the Massachusetts General Hospital Institute for Heart, Vascular and Stroke Care announces participation in a new Transatlantic Network of Excellence as part of a $6 million award from the Leducq Foundation. The Transatlantic Network of Excellence is made up of a team of researchers from around the world tasked with conducting first of its kind research on the genetic causes of atrial fibrillation (AF). The institute will serve as the coordinating site in the United States and Amsterdam Medical Center will serve as the coordinating site for Europe. The network will provide a platform for conducting cutting-edge and meaningful research into this common arrhythmia.